More news and press

An explosion of knowledge: Multiplexed interventional genomics
Discovery biology, pre-genomics, followed a linear path: develop a hypothesis, design an experiment and carefully control variables, one at a…
Read More
Genome Editors Begin Lining Up for Inscripta's Onyx Platform
The first of the fully automated benchtop instruments, designed to enable genome editing at unprecedented scale, will go to Jef Boeke of New…
Read More
Serial Biotech Entrepreneur Kevin Ness Has Raised $260 Million To Get His Genome-Engineering Device Into The Hands Of Every Scientist Who Wants One
Kevin Ness has made a career of building tools for biologists. Now, with the burgeoning field of synthetic biology booming, he’s ramping up his…
Read More
Inscripta pushes funding to $260 million as they launch genome editing platform
Inscripta presentations can begin with the advent of agriculture. Or even further back: The emergence of man.
Read More
$125 million for Inscripta may usher in the next wave of genetic engineering
In these waning days of the second decade of the twenty-first century, technologists and investors are beginning to lay the foundations for new,…
Read More
Biotech Investors Clamor for Crispr-Focused Tech in Surprise Round
Inscripta Inc. wasn’t seeking to raise capital when the genome-engineering company presented for the first time publicly at SynBioBeta, the…
Read More
Shaping the Emerging Bioeconomy
The ability to engineer biological systems to replace chemical processes is making the promise of the emerging bioeconomy a reality.
Read More
How Inscripta’s Onyx platform is making creativity the biologist’s only limiting factor
As technology improves and our capabilities increase, biology is moving from gene-scale to genome-scale, think one gene at a time to all…
Read More
Genomics Going from a Passive to an Active Science: John Stuelpnagel on the “Write” Revolution
I think the next level of biological discovery is going to be where you can actively perturb the system — it’s called a cell — and then ask what …
Read More
Watch Kevin Ness’ keynote during SynBioBeta 2019: Digital Genome Engineering – Unlocking the Unlimited Potential of Biology
On opening day of SynBioBeta 2019 in San Francisco, CA, Kevin Ness, CEO of Inscripta, announced the company’s Onyx platform: the world’s first…
Read More
1 of 3